Gene editing and CRISPR in the clinic: current and future perspectives

Genome editing technologies, particularly those based on zinc-finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), and CRISPR (clustered regularly interspaced short palindromic repeat DNA sequences)/Cas9 are rapidly progressing into clinical trials. Most clinical use of...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirakawa, Matthew P., Krishnakumar, Raga, Timlin, Jerilyn A., Carney, James P., Butler, Kimberly S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2020
Materias:
Biotechnology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7146048/
https://www.ncbi.nlm.nih.gov/pubmed/32207531
http://dx.doi.org/10.1042/BSR20200127

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7146048/
https://www.ncbi.nlm.nih.gov/pubmed/32207531
http://dx.doi.org/10.1042/BSR20200127

Ejemplares similares